Quantitative susceptibility mapping of dentate nucleus iron in SCA6 and SCA31: comparison with pathological findings [0.03%]
SCA6和SCA31中铁定量磁化率mapping的表征及其与病理结果的比较研究
Risa Kagaya,Noriko Sato,Yuko Saito et al.
Risa Kagaya et al.
Background: Spinocerebellar ataxia type 6 (SCA6) and 31 (SCA31) exhibit similar clinical and radiological features and have traditionally been distinguishable only through genetic testing. We focused on iron deposition in...
Comparative Study
Journal of neurology. 2026 Mar 17;273(4):213. DOI:10.1007/s00415-026-13744-x 2026
Real-world safety of satralizumab in neuromyelitis optica spectrum disorder: a FAERS-based risk stratification study [0.03%]
基于FAERS的危险分层研究中的视神经脊髓炎谱系障碍患者的_satralizumab_真实世界安全性分析
Xiuwen Zhang,Xiaomei Xiong,Jiaqi Wei et al.
Xiuwen Zhang et al.
Background: Satralizumab, an interleukin-6 receptor monoclonal antibody, is an established therapy for neuromyelitis optica spectrum disorder (NMOSD). While randomized trials have demonstrated their efficacy and short-ter...
Investigating the impact of migraine on short-term and working memory: a systematic review and meta-analysis [0.03%]
偏头痛对短期记忆和工作记忆的影响：系统评价和荟萃分析
Kenya McKay,Kate Kelly
Kenya McKay
Objective: To conduct a systematic review and meta-analysis on past research to ascertain the impact that experiencing migraines has on memory. Specifically, this research explores the short-term and working memory domain...
Prevalence and profiles of clinically diagnosed autoimmune cerebellar ataxia in a Japanese nationwide survey [0.03%]
日本全国调查中临床诊断的自身免疫性小脑共济失调的流行病学特征
Shintaro Fujii,Hiroaki Yaguchi,Akihiko Kudo et al.
Shintaro Fujii et al.
Background: Autoimmune cerebellar ataxia (ACA) is a potentially treatable cause of cerebellar dysfunction, but remains underrecognized because of diagnostic challenges, including limited access to autoantibody testing and...
Multicenter Study
Journal of neurology. 2026 Mar 17;273(4):215. DOI:10.1007/s00415-026-13758-5 2026
Lazaros C Triarhou
Lazaros C Triarhou
Published Erratum
Journal of neurology. 2026 Mar 17;273(4):216. DOI:10.1007/s00415-026-13708-1 2026
Targeted neurological screening for RFC1-related disease in unexplained chronic cough [0.03%]
RFC1相关疾病的神经学筛查在病因不明的慢性咳嗽中的应用
Vicente Gajate-García,María Fenollar-Cortés,Juan Luis Rodríguez-Hermosa et al.
Vicente Gajate-García et al.
Background: Cerebellar ataxia, neuropathy, and vestibular areflexia syndrome (CANVAS) is caused by biallelic pathogenic repeat expansions in the RFC1 gene. Chronic cough can precede the neurological features of CANVAS by ...
Correlating symptoms and skin α-synuclein seeding parameters in olfactory dysfunction and Lewy body dementia [0.03%]
嗅觉障碍和路易体痴呆症状与皮肤α-突触核蛋白播种参数的相关性研究
Oskar H McWilliam,Remarh Bsoul,Aušrinė Areškevičiūtė et al.
Oskar H McWilliam et al.
Objective: We investigated profiles of clinical symptoms and kinetic α-synuclein seed amplification assay (αSyn-SAA) parameters in skin across the spectrum of Lewy body disease by comparing normosmic healthy controls (H...
Anna Howard,Moses Mo,Caralyn Bencsik et al.
Anna Howard et al.
Background: Status epilepticus (SE) is a neurological emergency characterized by prolonged or recurrent seizures leading to secondary brain injury, morbidity and mortality. Timely and aggressive management is essential to...
Prognosis and outcomes in functional neurological disorder: a PRISMA-compliant systematic review with subtype-specific synthesis and clinical translation [0.03%]
符合PRISMA的系统性综述：功能神经性疾病预后和结局的亚型特异性综合与临床转化研究
Ioannis Mavroudis,Foivos Petridis,Katerina Franekova et al.
Ioannis Mavroudis et al.
Objectives: To synthesise evidence on prognosis, functional outcomes, and prognostic factors across functional neurological disorder (FND) subtypes and age groups. ...
Trial of Edaravone for severe hypoxic ischemic encephalopathy in adults: a double-blind placebo-controlled study [0.03%]
edaravone治疗成人重度缺氧性脑病的疗效及安全性：双盲安慰剂对照试验
Saeed Razmeh,Abdol Azim Karimi,Amir Mohammad Dashti et al.
Saeed Razmeh et al.
Background: Hypoxic ischemic encephalopathy (HIE) is a severe brain injury that can lead to death and long-term disability. HIE can be treated with therapeutic hypothermia, and various adjuvant treatments (such as melaton...
Randomized Controlled Trial
Journal of neurology. 2026 Mar 14;273(3):207. DOI:10.1007/s00415-026-13723-2 2026